SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Form 8.3 - 1Spatial plc

14 Jan 2026 14:07

RNS Number : 9250O
Perpetual Limited
14 January 2026
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Perpetual Limited and its related bodies corporate

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

1Spatial plc

 

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

13/01/2026

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

10p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 3,235,000

2.89

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

 3,235,000

2.89

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GBP

10p ordinary

Sale

-65,000

0.679

10p ordinary

Sale

-500,000

0.6785

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

14/01/2026

Contact name:

Joe Allpress

Telephone number:

0044 207 7475686

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBIMITMTMBBJF
Date   Source Headline
31st Mar 20235:03 pmRNSSatisfaction of Deferred Consideration & TVR
14th Mar 20234:01 pmRNSTR-1: Notification of Major Holdings
6th Mar 20237:00 amRNSTrading Update and Notice of Results
18th Jan 20233:07 pmRNSExercise of Options and Total Voting Rights
15th Dec 20227:00 amRNSDirectorate Change
2nd Nov 20227:00 amRNSDirector Share Purchase & PDMR Dealing
28th Oct 20221:51 pmRNSExercise of Options
28th Sep 20227:00 amRNSInterim results
5th Sep 20227:00 amRNSTwo significant US contract wins
26th Aug 20227:00 amRNSNotice of Results and Investor Presentation
27th Jul 202211:46 amRNSDirector Share Purchases & PDMR Dealings
19th Jul 20227:00 amRNSContract with European aerospace company
11th Jul 20227:00 amRNSContract win
21st Jun 202212:15 pmRNSResult of AGM
21st Jun 20227:00 amRNSAGM Statement and Trading Update
20th Jun 202212:35 pmRNSHolding(s) in Company
8th Jun 20227:00 amRNSFirst significant contract with High Speed Two
23rd May 20227:00 amRNSFirst contract with the State of New York
18th May 20224:47 pmRNSReport and Accounts and Notice of AGM
16th May 20227:00 amRNSAttendance at the Mello Investor Conference
11th May 20227:00 amRNS$1.4m expansion contract with State of California
27th Apr 20227:00 amRNSFinal Results
6th Apr 20229:30 amRNSNotice of Results and Investor Presentation
4th Mar 20223:03 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTrading update
17th Feb 20227:01 amEQSEdison Investment Research Limited: 1Spatial (SPA) - Validating spatial data across the globe
16th Feb 20227:00 amRNSNG911 contract win with State of Montana
7th Dec 20217:00 amRNSMulti-year contract with Rural Payments Agency
19th Oct 20215:15 pmRNSHolding(s) in Company
19th Oct 20212:18 pmRNSHolding(s) in Company
13th Oct 20217:00 amRNSMulti-year framework agreement
29th Sep 20217:00 amRNSInterim Results
27th Sep 20217:00 amRNSPartnership Contract Win for UK Government project
13th Sep 20217:00 amRNSContract to support UK Geospatial Commission
20th Aug 20217:00 amRNSNotice of Results
13th Jul 20217:00 amRNS1Spatial unveils new 1Integrate 3D rules engine
23rd Jun 202112:11 pmRNSResult of AGM
23rd Jun 20217:00 amRNSAGM Statement
3rd Jun 20212:44 pmRNSHolding(s) in Company - Replacement
3rd Jun 202112:51 pmRNSHolding(s) in Company
26th May 20211:24 pmRNSReport and Accounts and Notice of AGM
17th May 20217:00 amRNSUK Patent Granted
28th Apr 202112:41 pmRNSDirector Share Purchases
28th Apr 20217:00 amRNSFinal Results
15th Apr 20217:00 amRNSGoogle, Inc extends contract with 1Spatial
1st Apr 20217:00 amRNSMulti Year Contract
24th Mar 202110:26 amRNSHolding(s) in Company
19th Mar 20217:00 amRNSEsri Partner Network Award
18th Mar 20217:00 amRNSIntegration Update
12th Mar 20213:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.